Buscar | Friends - Best Social Network - החברים

Sindhuri Kotamraju agregó una foto Health
2025-09-22 13:33:17

ACLF Market Innovations: Seal Rock–GENFIT Collaboration Expands Novel Liver Disease Therapies
The global Acute On Chronic Liver Failure (ACLF) Market was valued at US$ 3.2 billion in 2023 and is projected to reach US$ 5.8 billion by 2031, with a compound annual growth rate (CAGR) of 7.2% during the forecast period 2024-2031, according to DataM Intelligence. Acute-on-Chronic Liver Failure (ACLF) is a severe syndrome involving rapid liver function deterioration in patients with chronic...

0 Commentarios 0 Acciones 350 Views 0 Vista previa

Please log in to like, share and comment!
Sindhuri Kotamraju agregó una foto Health
2025-07-23 12:49:37

Cat Allergy in Human Market Gains Momentum with Novel Vaccine Research
“Cat Allergy in Human Market reached US$ 0.73 billion in 2023 and is expected to reach US$ 1.19 billion by 2032, growing at a CAGR of 5.6% during the forecast period 2024-2032”,according to DataM intelligence report. Download Sample Report: https://www.datamintelligence.com/research-report/cat-allergy-in-human-market?sindhuri Cat allergy in humans is an allergic reaction...

0 Commentarios 0 Acciones 1K Views 0 Vista previa

Please log in to like, share and comment!
Sindhuri Kotamraju agregó una foto Health
2025-10-17 12:07:34

GO Treatment Market Growth Catalyzed by Novel IGF-1R Inhibitors and Targeted Therapies
The global Graves ophthalmopathy (GO) treatment market growth was valued at US$ 2.09 billion in 2024 and is projected to reach US$ 3.01 billion by 2033, growing at a CAGR of 4.2% during the forecast period. Download Sample PDF: Market Overview Graves ophthalmopathy, also known as thyroid eye disease (TED), is a serious autoimmune condition affecting the orbit around the eyes. It...

0 Commentarios 0 Acciones 223 Views 0 Vista previa

Please log in to like, share and comment!
Sindhuri Kotamraju agregó una foto Health
2025-09-18 10:51:06

Refractory Status Epileptics Drugs Market Sees Innovation with IV Ganaxolone and Novel Anesthetic Agents.
The global Refractory Status Epileptics Drugs Market is experiencing steady growth, driven by the rising incidence of refractory status epilepticus (RSE), a severe neurological emergency characterized by persistent seizures unresponsive to initial treatments like benzodiazepines. RSE affects up to 40% of status epilepticus cases, often linked to acute symptomatic etiologies such as infections...

0 Commentarios 0 Acciones 253 Views 0 Vista previa

Please log in to like, share and comment!